![Nicolas Poirier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicolas Poirier
Inga fler pågående positioner
Förmögenhet: 4 M $ per 2026-08-31
Profil
Nicolas Poirier worked as a Project Manager at Effimune SA. From 2016 to 2026, Dr. Poirier worked at OSE Immunotherapeutics SA, serving as Chief Scientific Officer from 2025 to 2026.
Dr. Poirier completed undergraduate studies at Centre d'Etudes Supérieures de Techniques Industrielles and graduate degrees at the University of Nantes and Louis Pasteur University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-09-12 | 1 131 603 ( 4,8 % ) | 4 M $ | 2026-08-31 |
Tidigare kända positioner av Nicolas Poirier
| Företag | Position | Slut |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Verkställande Direktör | 2025-10-02 |
Effimune SA
 Effimune SA BiotechnologyHealth Technology Engages in the research and development of drugs for transplantation and immune-mediated diseases | Företagsledare/Principal | - |
Nicolas Poiriers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
36
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
University of Nantes
 University of Nantes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Effimune SA
Effimune SA BiotechnologyHealth Technology Engages in the research and development of drugs for transplantation and immune-mediated diseases | Health Technology |
Centre d'Etudes Supérieures de Techniques Industrielles
 Centre d'Etudes Supérieures de Techniques Industrielles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Louis Pasteur University
 Louis Pasteur University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
